CSE:MUSL - Post Discussion
Post by
waves1 on Jun 13, 2022 6:01pm
Reflecting on Q1 2022 financial results
Reflecting on Element Nutritional Sciences' ($ELMT.c $ELNSF) Q1 2022 financial results with today's rough market.
Main highlights:
- Revenue of $2.3M, up 559% from $0.3M in Q1 2021
- Increased gross margin to 40% in Q1 2022
- Expanded distribution footprint & entered US grocery channel for both Rejuvenate and JAKTRX
- Received global patent for their clinically proven amino acid formulation, extending IP protection beyond the US into foreign markets
The results were a significant milestone for $ELMT and set them up to continue on this growth trajectory going forward, especially given the recent completion of production trials for Rejuvenate as it's expected to increase $ELMT's profitability by 15-20%.
https://www.businesswire.com/news/home/20220530005440/en/Element-Nutritional-Sciences-Reports-Q1-2022-Financial-Performance
Be the first to comment on this post